Últimos Artículos de Diabetes, Obesity and Metabolism
- Effectiveness of GLP‐1RA according to different type 2 diabetes phenotypes: A retrospective study
- Ketosis and ketoacidosis in hospitalized patients receiving SGLT2 inhibitor therapy
- Screening for type 1 diabetes in patients with celiac or thyroid disease: Practical considerations
- Short‐term refractive and choroidal changes in response to glycaemic excursions: Assessing the influence of metabolic and hormonal factors
- CONFIDENCE in the safety and efficacy of dual therapy with an SGLT‐2 inhibitor and finerenone in patients with chronic kidney disease and type 2 diabetes
- Long‐term effectiveness of iGlarLixi treatment in people with type 2 diabetes in the United States: The soli‐durability 24‐month observational study
- Prevalence and concordance of cardiometabolic risk markers and health behaviour among couples after a gestational diabetes mellitus‐affected pregnancy
- Multimodal imaging reveals distinct cardiac benefits of dulaglutide versus dapagliflozin in a mouse model of glucotoxic cardiomyopathy
- Digitally enhanced ketogenic diet versus low‐fat diet for cardio‐renal‐metabolic health in a predominantly Hispanic adult population with overweight or obesity: Pilot randomised clinical trial
- Psychometric evaluation of the Adelphi Adherence Questionnaire (ADAQ©) in a type 2 diabetes mellitus population as a new measure of adherence and the complex factors influencing adherence in routine care
- Characteristics of changes in bone mineral density and body composition in obesity patients after metabolic and bariatric surgery: A prospective cohort study
- Sustained improvements in glycaemic and psychosocial outcomes for youth and caregivers using Omnipod 5 AID for 12 months
- Gestational diabetes risk associated with early pregnancy blood pressure characteristics and trajectories: A Chinese prospective cohort study
- Get ahead of the disease: Islet cell autoimmunity and preclinical phase of type 1 diabetes in general population of 1–9 year‐old children in the north‐eastern region of Poland—A summary of the first 18 months of the study
- Ethnicity and socioeconomic status do not influence glycaemic outcomes of a tubeless hybrid closed‐loop system (Omnipod® 5) in adults with type 1 diabetes
- Real‐world insights into incretin‐based therapy: Associations between changes in taste perception and appetite regulation in individuals with obesity and overweight: A cross‐sectional study
- GLY‐200, an oral pharmacologic duodenal exclusion drug, resulted in positive effects on glucose, lipids and bodyweight in patients with type 2 diabetes: Results of a randomized, double‐blind placebo‐controlled trial
- Combined GPR40 and GPR119 full agonism with K‐757 and K‐833 results in robust glucose lowering and modest weight loss in overweight/obese subjects with T2DM
- Protective effect of metformin against dementia in patients with obesity: Results from a global federated health network analysis
- Efficacy and safety of combination therapy using SGLT2 and DPP4 inhibitors to treat type 2 diabetes: An updated systematic review and meta‐analysis with focus on an Asian subpopulation